Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription 01.04.2024 1 Am J Hematol 4 Blood 1 BMC Cancer 1 Br J Haematol 2 Haematologica 2 J Clin Oncol 1 Leukemia

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. STUVER R, Mian A, Brown S, Devlin S, et al
   BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.
   Am J Hematol. 2024 Mar 25. doi: 10.1002/ajh.27291.
   PubMed        
   
   

   
   Blood

2. GROVER NS, Beaven AW
   T-cell lymphoma: the CAR-T revolution is coming.
   Blood. 2024;143:1201-1202.
   PubMed        
   
   
3. GIESSINGER J, Pullarkat ST
   An unusual presentation of lymphoplasmacytic lymphoma with isolated brachial plexus infiltration and amyloidosis.
   Blood. 2024;143:1315.
   PubMed        
   
   
4. 
   Zinzani PL, Thieblemont C, Melnichenko V, et al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170. Blood. 2023;142(2):141-145.
   Blood. 2024;143:1316.
   PubMed        
   
   
5. HILL LC, Rouce RH, Wu MJ, Wang T, et al
   Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
   Blood. 2024;143:1231-1241.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. MCILROY G, Lax S, Gaskell C, Jackson A, et al
   Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
   BMC Cancer. 2024;24:370.
   PubMed         Abstract available
   
   

   
   Br J Haematol

7. MERLI M, Costantini A, Tafuri S, Bavaro DF, et al
   Management of vaccinations in patients with non-Hodgkin lymphoma.
   Br J Haematol. 2024 Mar 26. doi: 10.1111/bjh.19422.
   PubMed         Abstract available
   
   

   
   Haematologica

8. BI C, Huang Y, Ali R, Wang F, et al
   MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.
   Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2023.283811.
   PubMed         Abstract available
   
   
9. PULCZYNSKI EJ, Simonsen MR, Kuittinen O, Fagerli UM, et al
   Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
   Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2024.285207.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

10. BINKLEY MS, Flerlage JE, Savage KJ, Akhtar S, et al
    International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    J Clin Oncol. 2024 Mar 26:JCO2301655. doi: 10.1200/JCO.23.01655.
    PubMed         Abstract available
    
    
11. MEHTA-SHAH N, Horwitz SM
    Failing Forward in Peripheral T-Cell Lymphoma.
    J Clin Oncol. 2024 Mar 26:JCO2302658. doi: 10.1200/JCO.23.02658.
    PubMed        
    
    

    
    Leukemia

12. OERTEL M, Ziepert M, Frontzek F, Nacke N, et al
    Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial.
    Leukemia. 2024 Mar 27. doi: 10.1038/s41375-024-02231.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.